BERGER FRANKLIN M
Related Filers (14)
- SEATTLE GENETICS INC /WA (27)
- FIVE PRIME THERAPEUTICS, INC. (19)
- IMMUNE DESIGN CORP. (12)
- Kezar Life Sciences, Inc. (12)
- PROTEOSTASIS THERAPEUTICS, INC. (11)
- Rain Oncology Inc. (9)
- ESSA Pharma Inc. (8)
- Atea Pharmaceuticals, Inc. (7)
- Tocagen Inc (6)
- Atreca, Inc. (6)
- VAXGEN INC (5)
- BIOTIME INC (3)
- EMISPHERE TECHNOLOGIES INC (2)
- Asterias Biotherapeutics, Inc. (1)
- Show More ...
Ownership (128)
4
Friday, 1/26/2024
Rain Oncology Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/22/2023
ESSA Pharma Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/16/2023
ESSA Pharma Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/11/2023
Rain Oncology Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/26/2023
Kezar Life Sciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/21/2023
Atea Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/16/2023
Kezar Life Sciences, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/15/2023
Atreca, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2023
ESSA Pharma Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/23/2022
Rain Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/15/2022
Atea Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/14/2022
Rain Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/1/2022
ESSA Pharma Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/19/2022
Rain Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/21/2022
Atea Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/17/2022
Kezar Life Sciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/10/2022
Atreca, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/22/2022
Kezar Life Sciences, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/23/2021
Rain Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/23/2021
Kezar Life Sciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/30/2021
Kezar Life Sciences, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/21/2021
Atea Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/11/2021
Atreca, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/18/2021
Rain Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/27/2021
Rain Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 4/22/2021
Rain Therapeutics Inc.: Initial statement of beneficial ownership of securities
4
Monday, 4/19/2021
FIVE PRIME THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/4/2021
ESSA Pharma Inc.: Statement of changes in beneficial ownership of securities
4/A
Tuesday, 1/26/2021
ESSA Pharma Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/11/2021
ESSA Pharma Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/3/2020
Atea Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/30/2020
Atea Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/29/2020
Atea Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
3
Thursday, 10/1/2020
ESSA Pharma Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 7/1/2020
PROTEOSTASIS THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 6/26/2020
Kezar Life Sciences, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/15/2020
Atreca, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/11/2020
Kezar Life Sciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/15/2020
FIVE PRIME THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/5/2020
Kezar Life Sciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/4/2019
FIVE PRIME THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 10/4/2019
Tocagen Inc: Statement of changes in beneficial ownership of securities
4
Monday, 7/1/2019
PROTEOSTASIS THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/27/2019
Kezar Life Sciences, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/24/2019
Atreca, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/19/2019
Atreca, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 6/12/2019
FIVE PRIME THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Friday, 5/31/2019
Tocagen Inc: Statement of changes in beneficial ownership of securities
4
Thursday, 4/4/2019
IMMUNE DESIGN CORP.: Statement of changes in beneficial ownership of securities
4
Monday, 1/7/2019
IMMUNE DESIGN CORP.: Statement of changes in beneficial ownership of securities
4
Friday, 10/26/2018
PROTEOSTASIS THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/27/2018
Kezar Life Sciences, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/25/2018
Tocagen Inc: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/20/2018
Kezar Life Sciences, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 6/19/2018
PROTEOSTASIS THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 5/14/2018
FIVE PRIME THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Monday, 1/8/2018
Immune Design Corp.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/19/2017
PROTEOSTASIS THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/1/2017
Immune Design Corp.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/26/2017
Immune Design Corp.: Statement of changes in beneficial ownership of securities
4
Monday, 8/7/2017
PROTEOSTASIS THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 5/12/2017
FIVE PRIME THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Friday, 4/21/2017
Tocagen Inc: Statement of changes in beneficial ownership of securities
3
Wednesday, 4/12/2017
Tocagen Inc: Initial statement of beneficial ownership of securities
4
Wednesday, 4/12/2017
Tocagen Inc: Statement of changes in beneficial ownership of securities
4
Friday, 1/6/2017
Immune Design Corp.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/20/2016
Immune Design Corp.: Statement of changes in beneficial ownership of securities
4
Monday, 12/19/2016
PROTEOSTASIS THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/15/2016
PROTEOSTASIS THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 5/23/2016
FIVE PRIME THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/26/2016
FIVE PRIME THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 4/21/2016
FIVE PRIME THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/17/2016
PROTEOSTASIS THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 2/12/2016
PROTEOSTASIS THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
3
Wednesday, 2/10/2016
PROTEOSTASIS THERAPEUTICS, INC.: Initial statement of beneficial ownership of securities
4
Wednesday, 1/6/2016
Immune Design Corp.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/24/2015
FIVE PRIME THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Friday, 9/4/2015
FIVE PRIME THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 7/2/2015
FIVE PRIME THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Friday, 6/19/2015
FIVE PRIME THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/16/2015
FIVE PRIME THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/21/2015
Immune Design Corp.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/29/2015
FIVE PRIME THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Friday, 1/16/2015
FIVE PRIME THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Friday, 1/9/2015
Immune Design Corp.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/2/2014
FIVE PRIME THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 7/31/2014
Immune Design Corp.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/23/2014
Immune Design Corp.: Initial statement of beneficial ownership of securities
4
Tuesday, 5/20/2014
FIVE PRIME THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/25/2014
SEATTLE GENETICS INC /WA: Statement of changes in beneficial ownership of securities
3
Friday, 9/27/2013
Asterias Biotherapeutics, Inc.: Initial statement of beneficial ownership of securities
3
Tuesday, 9/17/2013
FIVE PRIME THERAPEUTICS INC: Initial statement of beneficial ownership of securities
4
Friday, 8/30/2013
SEATTLE GENETICS INC /WA: Statement of changes in beneficial ownership of securities
4
Thursday, 8/22/2013
BIOTIME INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/3/2013
BIOTIME INC: Statement of changes in beneficial ownership of securities
3
Thursday, 5/23/2013
BIOTIME INC: Initial statement of beneficial ownership of securities
4
Tuesday, 5/21/2013
SEATTLE GENETICS INC /WA: Statement of changes in beneficial ownership of securities
4
Monday, 8/27/2012
SEATTLE GENETICS INC /WA: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/22/2012
SEATTLE GENETICS INC /WA: Statement of changes in beneficial ownership of securities
4
Thursday, 6/23/2011
SEATTLE GENETICS INC /WA: Statement of changes in beneficial ownership of securities